There were 1,717 press releases posted in the last 24 hours and 474,683 in the last 365 days.

Site Payment Paradigm Shift: Say Goodbye to Excel, New Webinar Hosted by Xtalks

/EINPresswire.com/ -- Global financial management in the biopharmaceutical industry is more important than ever and given sizable site payment allocations, you now can gain greater transparency and timely, accurate disbursement. There is an industry trend for Sponsors to separate payments from full service projects to drive more accurate, timely and cost effective payments. Medidata Payments are spearheading new and innovative processes and solutions to address these market demands.

Medidata logoMedidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics.Click here for high-resolution version

TORONTO, ON--(Marketwired - November 16, 2016) - Join this informative webinar to learn how your organization could benefit from just-in-time site payments. Medidata and INC Research will present a sponsor case study showing how this large sponsor moved from a full service model to a dedicated payments service, using a combination of Medidata Payments technology and INC payments administration delivering a seamless end to end solution.

Featured speakers include:

  • Victoria Moore, FCCA, Executive Director, Global Business Finance, INC Research
  • Shaun Williams, Director, Investigator Payments, INC Research
  • Marcus Thornton, Principal, Platform Adoption, Medidata
  • Nina Pruitt, Senior Director, Global Product Marketing, Medidata

The presentation will discuss the paradigm shift in payment tracking from excel or home-grown manual systems to more commercial, turn-key technology. These historical processes and systems leave little opportunity for sponsors and CROs to effectively plan and track payments as costs are incurred by the sites, which negatively impact site satisfaction and performance. Sponsors and CROs have historically been challenged to quickly produce detailed global forecasting and disburse accurate and timely site payments in the correct currency and applying the right exchange rate, VAT and withholding tax requirements. Sites battling cash flow problems and payment delays are a distraction from the work that they have been contracted to perform.

With a new EDC-driven payment process, Sponsors and CROs alike are easily able to project, trigger, calculate and disburse payments in any currency quickly and accurately. Sites receive their payments on time and the trial progresses seamlessly. It is the proverbial win-win for all.

For more information or to register for this complimentary event, visit: Site Payment Paradigm Shift: Say Goodbye to Excel.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/11/15/11G122184/Images/Medidata_Logo_Color_hex-616276042819.jpg

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.